{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:44:02Z","timestamp":1786160642912,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05335-6","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:27:44Z","timestamp":1786159664000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional outcomes and retreatment rates after iTIND implantation in a real-world Italian multicenter cohort: the importance of patient selection"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0712-2719","authenticated-orcid":false,"given":"Luca","family":"Cindolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Olivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Vittori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Lambertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Castellucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Domenico","family":"Salvaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Turbanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Piccolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"De Nunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"5335_CR1","unstructured":"Bachmann A, Descazeaud A, Emberton M, et al (2018) EAU: guidelines on male lower urinary tract symptoms ( LUTS ), including Benign Prostatic Obstruction ( BPO ). European Association Urol 123\u2013144"},{"key":"5335_CR2","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1016\/j.euf.2022.06.007","volume":"8","author":"C Manfredi","year":"2022","unstructured":"Manfredi C, Garc\u00eda-G\u00f3mez B, Arcaniolo D et al (2022) Impact of surgery for benign prostatic hyperplasia on sexual function: a systematic review and meta-analysis of erectile function and ejaculatory function. Eur Urol Focus 8:1711\u20131732. https:\/\/doi.org\/10.1016\/j.euf.2022.06.007","journal-title":"Eur Urol Focus"},{"key":"5335_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.euf.2024.12.008","volume":"11","author":"D Elterman","year":"2025","unstructured":"Elterman D, Kaplan SA (2025) Reimagining male lower urinary tract symptoms due to benign prostatic hyperplasia treatment: a new approach to first-line interventional therapy. Eur Urol Focus 11:508\u2013510. https:\/\/doi.org\/10.1016\/j.euf.2024.12.008","journal-title":"Eur Urol Focus"},{"key":"5335_CR4","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41391-024-00915-y","volume":"28","author":"C Cerrato","year":"2024","unstructured":"Cerrato C, Antoniou V, Somani BK (2024) Prostatic stents: a systematic review and analysis of functional outcomes and complication rate. Prostate Cancer Prostatic Dis 28:318\u2013327","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41391-024-00900-5","volume":"28","author":"L Lambertini","year":"2024","unstructured":"Lambertini L, Sandulli A, Coco S et al (2024) Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature. Prostate Cancer Prostatic Dis 28:639\u2013651","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR6","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41391-024-00892-2","volume":"28","author":"S Secco","year":"2024","unstructured":"Secco S, Olivero A, Longoni M et al (2024) Use of a Schelin catheter for transurethral intraprostatic anesthesia (TUIA) prior to iTIND procedure. Prostate Cancer Prostatic Dis 28:832\u2013833. https:\/\/doi.org\/10.1038\/s41391-024-00892-2","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR7","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41391-025-00971-y","volume":"28","author":"C Manfredi","year":"2025","unstructured":"Manfredi C, Spirito L, Quattrone C et al (2025) Rez\u016bm water vapor therapy vs. thulium laser enucleation for the treatment of benign prostatic hyperplasia in patients with large prostates: a multicenter prospective comparative study. Prostate Cancer Prostatic Dis 28:968\u2013977. https:\/\/doi.org\/10.1038\/s41391-025-00971-y","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41391-024-00923-y","volume":"28","author":"M Pacini","year":"2024","unstructured":"Pacini M, Lambertini L, Avesani G et al (2024) Single-port transvesical simple prostatectomy for the surgical treatment of benign prostatic hyperplasia: functional and continence outcomes. Prostate Cancer Prostatic Dis 28:451\u2013456. https:\/\/doi.org\/10.1038\/s41391-024-00923-y","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR9","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41391-025-00952-1","volume":"29","author":"A Alberti","year":"2025","unstructured":"Alberti A, Lo Re M, Nicoletti R et al (2025) Transperineal laser ablation in the management of benign prostatic hyperplasia: an updated systematic review and pooled analysis. Prostate Cancer Prostatic Dis 29:222\u2013238","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41391-025-00985-6","volume":"29","author":"SA Kaplan","year":"2025","unstructured":"Kaplan SA, Elterman DS (2025) New BPH therapy classification: what really FITs? Prostate Cancer Prostatic Dis 29:98\u201399","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41391-025-00986-5","volume":"29","author":"C De Nunzio","year":"2025","unstructured":"De Nunzio C, Lombardo R, Cicione A et al (2025) MISTs for benign prostatic hyperplasia as first line interventional treatment: Alea iacta est? Prostate Cancer Prostatic Dis 29:95\u201397","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/s41391-025-00984-7","volume":"28","author":"D Elterman","year":"2025","unstructured":"Elterman D, Perscky I, Urena R et al (2025) Feasibility and safety study of the Flostent\u2122 system (RAPID-I). Prostate Cancer Prostatic Dis 28:989\u2013992. https:\/\/doi.org\/10.1038\/s41391-025-00984-7","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR13","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/bju.14608","volume":"123","author":"F Porpiglia","year":"2019","unstructured":"Porpiglia F, Fiori C, Amparore D et al (2019) Second-generation of temporary implantable nitinol device for the relief of lower urinary tract symptoms due to benign prostatic hyperplasia: results of a prospective, multicentre study at 1 year of follow-up. BJU Int 123:1061\u20131069. https:\/\/doi.org\/10.1111\/bju.14608","journal-title":"BJU Int"},{"key":"5335_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-020-03418-2","author":"C De Nunzio","year":"2020","unstructured":"De Nunzio C, Cantiello F, Fiori C et al (2020) Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study. World J Urol. https:\/\/doi.org\/10.1007\/s00345-020-03418-2","journal-title":"World J Urol"},{"key":"5335_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s11934-019-0912-6","author":"D Amparore","year":"2019","unstructured":"Amparore D, De Cillis S, Volpi G et al (2019) First- and second-generation temporary implantable nitinol devices as minimally invasive treatments for BPH-related LUTS: systematic review of the literature. Curr Urol Rep. https:\/\/doi.org\/10.1007\/s11934-019-0912-6","journal-title":"Curr Urol Rep"},{"key":"5335_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/J.EUF.2023.03.004","volume":"9","author":"M Baboudjian","year":"2023","unstructured":"Baboudjian M, Cornu JN, Gondran-Tellier B et al (2023) Pharmacologic and surgical retreatment after office-based treatments for benign prostatic hyperplasia: a systematic review. Eur Urol Focus 9:727\u2013733. https:\/\/doi.org\/10.1016\/J.EUF.2023.03.004","journal-title":"Eur Urol Focus"},{"key":"5335_CR17","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1007\/S00345-020-03140-Z","volume":"38","author":"G Kadner","year":"2020","unstructured":"Kadner G, Valerio M, Giannakis I et al (2020) Second generation of temporary implantable nitinol device (iTind) in men with LUTS: 2 year results of the MT-02-study. World J Urol 38:3235\u20133244. https:\/\/doi.org\/10.1007\/S00345-020-03140-Z","journal-title":"World J Urol"},{"key":"5335_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/08927790261451068","author":"L Cindolo","year":"2026","unstructured":"Cindolo L, Vittori G, Gallo F et al (2026) Patient satisfaction and decision regret in patients undergone temporary implantable nitinol device procedure for BPH\/LUTS: an Italian, real life, multicenter study. J Endourol. https:\/\/doi.org\/10.1177\/08927790261451068","journal-title":"J Endourol"},{"key":"5335_CR19","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/S41391-023-00686-Y","volume":"26","author":"M Sibona","year":"2023","unstructured":"Sibona M, Destefanis P, Vercelli E et al (2023) Ejaculation physiology and dysfunction after BPH surgery: the role of the new MISTs. Prostate Cancer Prostatic Dis 26:475\u2013482. https:\/\/doi.org\/10.1038\/S41391-023-00686-Y","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5335_CR20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/J.UROLOGY.2020.12.022","volume":"153","author":"B Chughtai","year":"2021","unstructured":"Chughtai B, Elterman D, Shore N et al (2021) The iTind temporarily implanted nitinol device for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a multicenter, randomized, controlled trial. Urology 153:270\u2013276. https:\/\/doi.org\/10.1016\/J.UROLOGY.2020.12.022","journal-title":"Urology"},{"key":"5335_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/J.EURURO.2025.09.004","volume":"89","author":"A Franco","year":"2026","unstructured":"Franco A, Ditonno F, Manfredi C et al (2026) Systematic review and pooled analysis of functional and sexual outcomes of minimally invasive surgical treatments for benign prostatic obstruction. Eur Urol 89:318\u2013331. https:\/\/doi.org\/10.1016\/J.EURURO.2025.09.004","journal-title":"Eur Urol"},{"key":"5335_CR22","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.euf.2024.04.006","volume":"10","author":"F Ditonno","year":"2024","unstructured":"Ditonno F, Manfredi C, Licari LC et al (2024) Benign prostatic hyperplasia surgery: a snapshot of trends, costs, and surgical retreatment rates in the USA. Eur Urol Focus 10:826\u2013832. https:\/\/doi.org\/10.1016\/j.euf.2024.04.006","journal-title":"Eur Urol Focus"},{"key":"5335_CR23","doi-asserted-by":"publisher","DOI":"10.1177\/03915603251406809","author":"A Olivero","year":"2026","unstructured":"Olivero A, De Cillis S, Amparore D et al (2026) Twenty-four months failure rate and functional outcomes comparison after implantable nitinol device (iTIND) and prostatic urethral lift (Urolift): real world multicenter study. Urologia (Basel). https:\/\/doi.org\/10.1177\/03915603251406809","journal-title":"Urologia (Basel)"},{"key":"5335_CR24","doi-asserted-by":"publisher","first-page":"CD006732","DOI":"10.1002\/14651858.CD006732.PUB3","volume":"15","author":"F L\u00e9gar\u00e9","year":"2014","unstructured":"L\u00e9gar\u00e9 F, Stacey D, Turcotte S et al (2014) Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev 15:CD006732. https:\/\/doi.org\/10.1002\/14651858.CD006732.PUB3","journal-title":"Cochrane Database Syst Rev"},{"key":"5335_CR25","unstructured":"Cindolo L (2026) Counseling is counseling is counseling. Prostate Cancer Prostatic Dis in press"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05335-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05335-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T03:27:47Z","timestamp":1786159667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05335-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":25,"alternative-id":["5335"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05335-6","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"5 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest related to this study.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}